Rubius Therapeutics Price Target & Analyst Ratings (NASDAQ:RUBY)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

5 Wall Street analysts have issued ratings and price targets for Rubius Therapeutics in the last 12 months. Their average twelve-month price target is $25.00, suggesting that the stock has a possible upside of 166.52%. The high price target for RUBY is $40.00 and the low price target for RUBY is $4.00. There are currently 1 sell rating and 4 buy ratings for the stock, resulting in a consensus rating of "Buy."

Rubius Therapeutics (NASDAQ:RUBY) Consensus Price Target History

Rubius Therapeutics (NASDAQ:RUBY) Analyst Ratings History

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
9/9/2019	Robert W. Baird	Initiated Coverage	Underperform	$4.00 ➝ $4.00	High
8/29/2019	JPMorgan Chase & Co.	Lower Price Target	Overweight	$27.00 ➝ $22.00	High
6/26/2019	HC Wainwright	Initiated Coverage	Buy ➝ Buy	$40.00	High
5/30/2019	Guggenheim	Initiated Coverage	Buy	$25.00	High
12/19/2018	Morgan Stanley	Lower Price Target	Overweight ➝ Overweight	$37.00 ➝ $34.00	High
8/13/2018	Leerink Swann	Initiated Coverage	Outperform		High
8/13/2018	Jefferies Financial Group	Initiated Coverage	Buy	$40.00	High

(Data available from 10/22/2017 forward)